These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7185119)

  • 21. Oligoclonal bands measured in unconcentrated cerebrospinal fluid and other biochemical parameters in multiple sclerosis.
    Kurzepa J; Nastaj M; Mitosek-Szewczyk K; Bartosik-Psujek H; Stelmasiak Z
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):392-6. PubMed ID: 16146115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.
    Link H; Huang YM
    J Neuroimmunol; 2006 Nov; 180(1-2):17-28. PubMed ID: 16945427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biologic versus clinical MS.
    Paty DW; Eisen KA; Oger JJ; Purves SJ; Kastrukoff LF; Low M; Hashimoto SA; Brandjes V; Hooge JJ; Robertson W
    Neurology; 1989 Jan; 39(1):151-3. PubMed ID: 2642612
    [No Abstract]   [Full Text] [Related]  

  • 24. Viruses and multiple sclerosis.
    Gilden DH
    JAMA; 2001 Dec; 286(24):3127-9. PubMed ID: 11754680
    [No Abstract]   [Full Text] [Related]  

  • 25. Sequential changes in oligoclonal patterns during the course of multiple sclerosis.
    Thompson EJ; Kaufmann P; Rudge P
    J Neurol Neurosurg Psychiatry; 1983 Jun; 46(6):547-50. PubMed ID: 6875587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The hot bath test in multiple sclerosis: comparison with visual evoked responses and oligoclonal bands.
    Rolak LA; Ashizawa T
    Acta Neurol Scand; 1985 Jul; 72(1):65-7. PubMed ID: 4050319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct.
    Imrell K; Landtblom AM; Hillert J; Masterman T
    Neurology; 2006 Sep; 67(6):1062-4. PubMed ID: 17000979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis.
    Obermeier B; Mentele R; Malotka J; Kellermann J; Kümpfel T; Wekerle H; Lottspeich F; Hohlfeld R; Dornmair K
    Nat Med; 2008 Jun; 14(6):688-93. PubMed ID: 18488038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roles of immunoglobulins and B cells in multiple sclerosis: from pathogenesis to treatment.
    Antel J; Bar-Or A
    J Neuroimmunol; 2006 Nov; 180(1-2):3-8. PubMed ID: 16934338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CSF analysis in suspected MS: do bands aid?
    Hintzen RQ; Giovannoni G
    Neurology; 2008 Mar; 70(13 Pt 2):1059-60. PubMed ID: 18362264
    [No Abstract]   [Full Text] [Related]  

  • 31. Oligoclonal immunoglobulins and multiple sclerosis.
    Thompson EJ
    Br Med J; 1979 Jun; 1(6176):1489. PubMed ID: 466082
    [No Abstract]   [Full Text] [Related]  

  • 32. Cerebrospinal fluid oligoclonal bands and progression of disability of multiple sclerosis.
    Deleu D
    Eur J Neurol; 2008 Apr; 15(4):e23; author reply e24. PubMed ID: 18353119
    [No Abstract]   [Full Text] [Related]  

  • 33. [The diagnostic value of nuclear magnetic resonance tomography, multimodal evoked potentials and cerebrospinal fluid examination in multiple sclerosis].
    Staffen W; Trinka E; Ladurner G
    Nervenarzt; 1993 Apr; 64(4):226-32. PubMed ID: 8506010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oligoclonal bands in multiple sclerosis: clinical-pathologic correlation.
    Farrell MA; Kaufmann JC; Gilbert JJ; Noseworthy JH; Armstrong HA; Ebers GC
    Neurology; 1985 Feb; 35(2):212-8. PubMed ID: 3969209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-reactive idiotypy in cerebrospinal fluid immunoglobulins in multiple sclerosis.
    LaGanke CC; Freeman DW; Whitaker JN
    Ann Neurol; 2000 Jan; 47(1):87-92. PubMed ID: 10632105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrospinal fluid analysis in the diagnosis of multiple sclerosis.
    Thompson EJ; Freedman MS
    Adv Neurol; 2006; 98():147-60. PubMed ID: 16400832
    [No Abstract]   [Full Text] [Related]  

  • 37. The specificity of oligoclonal bands in multiple sclerosis.
    Lipton HL
    Ann Neurol; 2009 Jun; 65(6):621-2. PubMed ID: 19557872
    [No Abstract]   [Full Text] [Related]  

  • 38. The significance of oligoclonal bands in multiple sclerosis: relevance of demographic and clinical features, and immunogenetic backgrounds.
    Idiman E; Ozakbas S; Dogan Y; Kosehasanogullari G
    J Neuroimmunol; 2009 Jul; 212(1-2):121-4. PubMed ID: 19457560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased intracranial pressure in a case of pediatric multiple sclerosis.
    Williams BJ; Skinner HJ; Maria BL
    J Child Neurol; 2008 Jun; 23(6):699-702. PubMed ID: 18539995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Relation between the clinical and cerebrospinal fluid parameters in multiple sclerosis, with special reference to subjects without oligoclonal IgG in the cerebrospinal fluid].
    Poloni M; Rocchelli B; Mazzarello P; Delodovici M
    Riv Neurol; 1981; 51(2):69-80. PubMed ID: 7244541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.